Les biomarqueurs à rechercher en 2012 et dans le futur proche dans les cancers bronchiques non à petites cellules (CBNPC)

French Intergroup (IFCT) with French NCI support, initiated a large prospective study, Biomarqueurs-France, to analyse the impact of the 17 000 routine yearly biomarkers analyses performed, by regional molecular biology platforms, on the routine care of French patients. This study will contribute to validate the biomarkers use, as early as at time of cancer diagnosis. Those biomarkers currently help us, or will help us in near future, for the routine care of lung cancer patients.